Research Topic · Peer-Reviewed

Covid-19 Vaccines

COVID-19 vaccines are immunizing agents developed to protect against disease caused by SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic that began in late 2019, by priming the immune system to recognize and respond to the virus. These vaccines use several technological platforms, including messenger…

Curated from this journal's research 📚 12 peer-reviewed articles cited Cited 11× across the literature 🔖 ISSN 2692-1537 🗓 Reviewed July 2026

Overview

COVID-19 vaccines are immunizing agents developed to protect against disease caused by SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic that began in late 2019, by priming the immune system to recognize and respond to the virus. These vaccines use several technological platforms, including messenger RNA, viral-vector, protein-subunit, and inactivated-virus designs, many of which present the viral spike protein or its genetic code to elicit protective antibody and cellular immune responses. Developed and authorized at unprecedented speed during a global health emergency, they have been central to efforts to reduce severe illness, hospitalization, and death, while their effectiveness is influenced by viral evolution and the emergence of new variants. Beyond immunology and efficacy, the success of vaccination programs depends on uptake, which is shaped by access, trust, and vaccine hesitancy, as well as by considerations of safety and rare adverse events. Research published in this area reflects these themes, including COVID-19 vaccine development, prospects, and challenges; the dynamics of infection and modeling of vaccination needs; spike-protein effects on interferon and cytokine expression; predictors of vaccine hesitancy and uptake among the general population, healthcare workers, and people living with HIV; reported post-vaccination conditions; and analyses of misinformation and conspiracy theories surrounding the pandemic.

Research published in this journal

12 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 12 articles above have been cited 11 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Covid-19 Vaccines, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in International Journal of Coronaviruses (ISSN 2692-1537).

Journal editorial board
Dr. Omeed Memar · USA Dr. SUDIPTI GUPTA · United States Dr. Jose Luis Turabian · Spain

This page summarises published research for orientation; it is not medical or professional advice.